Cerebrovascular Complications of l-Asparaginase in the Therapy of Acute Lymphoblastic Leukemia

Authors:
  • LPLuciana Porto
    Luciana Porto
  • HLHeinrich Lanfermann
    Heinrich Lanfermann
  • GJGert Jacobi
    Gert Jacobi
  • DSDirk Schwabe
    Dirk Schwabe
  • HBHansjosef Böhles
    Hansjosef Böhles

Abstract
L-asparaginase is frequently used in combination therapy for the treatment of lymphoid malignancies. We report 5 children aged between 8 and 14 years with neurologic complications presenting with headache and seizures during the first three weeks of l-asparaginase treatment. Three patients had venous thrombosis, one presented a parenchymal hemorrhage, and one showed a peculiar encephalopathy with extended cortical and subcortical lesions suggesting a neurotoxic reaction. Decreased fibrinogen and antithrombin III levels were found. Early MRI is critical even in cases with mild neurologic symptoms. Diagnosis should be followed by early cessation of l-asparaginase application.

This publication has 13 references indexed in Scilit: